Glenmark Life Sciences IPO Details
Glenmark Life Sciences Ltd, API Subsidiary Company of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India (SEBI) for an Initial Public Offer (IPO) to raise Rs 1,160 crore.
About the Company
Glenmark Life Sciences is a leading developer and manufacturer of select high value, non-commoditized Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas.
Company develop, manufacture and supply high quality Active Pharmaceutical Ingredients (APIs) to our partners globally.
|Issue Type||Book Built Issue|
|Issue Price||₹0 to ₹0|
|Issue Size||₹0 per share|
|Face Value||₹0 per share|
|Market Lot||0 Shares|
|Ipo Open On||No Update|
|Ipo Closes On||Na|
|Credit To Demat||Na|
Financials of the Company
|Total Income||14,184.72 Cr||15,493.03 Cr||8,868.65 Cr|
|Total Expense||10,881.50 Cr||11,282.36 Cr||6,585.68 Cr|
|Profit/Loss||2,468.97 Cr||3,130.98 Cr||1,955.92 Cr|
|Min||1 Lot||0 shares||₹0|
|Max||0 Lot||0 shares||₹0|
Company Contact Detail
|GLENMARK LIFE SCIENCES LIMITED|
Plot No. 170-172, Chandramouli Industrial Estate, Mohol Bazarpeth, Solapur 413 213, Maharashtra, India
Tel No.: +91 2189 234456
Email: [email protected]
|Kfin Technologies Private Limited|
Selenium, Tower B, Plot No. - 31 and 32 Financial
District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500
032 Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]
Lead Manager of IPO
|Kotak Mahindra Capital|
|Goldman Sachs Securities|
|BOB Capital Market|
|SBI Capital Market|
Frequently Asked Questions
Currently, there are no update about the issue price of Glenmark Lifescience ipo.
Issue size of Glenmark Lifescience ipo is Rs.0 crore.
Kfin Technologies Private Ltd is the Registrar of Glenmark Lifescience ipo.
There are 6 Lead managers of this ipo.
Kotak Mahindra Capital BofA Securities Goldman Sachs Securities DAM Capital BOB Capital Market SBI Capital Market
Hey, thank for reading this article.
Feel free to share your thoughts and questions in comment.
Don't forget to share it with your friends, family and colleagues.